Literature DB >> 23032386

Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study.

Patience J Gallagher1, Victor Castro, Maurizio Fava, Jeffrey B Weilburg, Shawn N Murphy, Vivian S Gainer, Susanne E Churchill, Isaac S Kohane, Dan V Iosifescu, Jordan W Smoller, Roy H Perlis.   

Abstract

OBJECTIVE It has been suggested that there is a mechanism by which nonsteroidal anti-inflammatory drugs (NSAIDs) may interfere with antidepressant response, and poorer outcomes among NSAID-treated patients were reported in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. To attempt to confirm this association in an independent population-based treatment cohort and explore potential confounding variables, the authors examined use of NSAIDs and related medications among 1,528 outpatients in a New England health care system. METHOD Treatment outcomes were classified using a validated machine learning tool applied to electronic medical records. Logistic regression was used to examine the association between medication exposure and treatment outcomes, adjusted for potential confounding variables. To further elucidate confounding and treatment specificity of the observed effects, data from the STAR*D study were reanalyzed. RESULTS NSAID exposure was associated with a greater likelihood of depression classified as treatment resistant compared with depression classified as responsive to selective serotonin reuptake inhibitors (odds ratio=1.55, 95% CI=1.21-2.00). This association was apparent in the NSAIDs-only group but not in those using other agents with NSAID-like mechanisms (cyclooxygenase-2 inhibitors and salicylates). Inclusion of age, sex, ethnicity, and measures of comorbidity and health care utilization in regression models indicated confounding; association with outcome was no longer significant in fully adjusted models. Reanalysis of STAR*D results likewise identified an association in NSAIDs but not NSAID-like drugs, with more modest effects persisting after adjustment for potential confounding variables. CONCLUSIONS These results support an association between NSAID use and poorer antidepressant outcomes in major depressive disorder but indicate that some of the observed effect may be a result of confounding.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23032386      PMCID: PMC3787520          DOI: 10.1176/appi.ajp.2012.11091325

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  19 in total

1.  Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.

Authors:  Jennifer L Warner-Schmidt; Kimberly E Vanover; Emily Y Chen; John J Marshall; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Instrumenting the health care enterprise for discovery research in the genomic era.

Authors:  Shawn Murphy; Susanne Churchill; Lynn Bry; Henry Chueh; Scott Weiss; Ross Lazarus; Qing Zeng; Anil Dubey; Vivian Gainer; Michael Mendis; John Glaser; Isaac Kohane
Journal:  Genome Res       Date:  2009-07-14       Impact factor: 9.043

3.  Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale.

Authors:  M D Miller; C F Paradis; P R Houck; S Mazumdar; J A Stack; A H Rifai; B Mulsant; C F Reynolds
Journal:  Psychiatry Res       Date:  1992-03       Impact factor: 3.222

4.  Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model.

Authors:  R H Perlis; D V Iosifescu; V M Castro; S N Murphy; V S Gainer; J Minnier; T Cai; S Goryachev; Q Zeng; P J Gallagher; M Fava; J B Weilburg; S E Churchill; I S Kohane; J W Smoller
Journal:  Psychol Med       Date:  2011-06-20       Impact factor: 7.723

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

7.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

8.  Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

Authors:  A John Rush; Maurizio Fava; Stephen R Wisniewski; Philip W Lavori; Madhukar H Trivedi; Harold A Sackeim; Michael E Thase; Andrew A Nierenberg; Frederic M Quitkin; T Michael Kashner; David J Kupfer; Jerrold F Rosenbaum; Jonathan Alpert; Jonathan W Stewart; Patrick J McGrath; Melanie M Biggs; Kathy Shores-Wilson; Barry D Lebowitz; Louise Ritz; George Niederehe
Journal:  Control Clin Trials       Date:  2004-02

9.  Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants.

Authors:  Victor M Castro; Patience J Gallagher; Caitlin C Clements; Shawn N Murphy; Vivian S Gainer; Maurizio Fava; Jeffrey B Weilburg; Susanne E Churchill; Isaac S Kohane; Dan V Iosifescu; Jordan W Smoller; Roy H Perlis
Journal:  BMJ Open       Date:  2012-03-30       Impact factor: 2.692

10.  Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records.

Authors:  John S Brownstein; Shawn N Murphy; Allison B Goldfine; Richard W Grant; Margarita Sordo; Vivian Gainer; Judith A Colecchi; Anil Dubey; David M Nathan; John P Glaser; Isaac S Kohane
Journal:  Diabetes Care       Date:  2009-12-15       Impact factor: 19.112

View more
  20 in total

1.  Improving risk prediction for depression via Elastic Net regression - Results from Korea National Health Insurance Services Data.

Authors:  Min-Hyung Kim; Samprit Banerjee; Sang Min Park; Jyotishman Pathak
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

Review 2.  Targeting the immune system in the treatment of bipolar disorder.

Authors:  Joshua D Rosenblat
Journal:  Psychopharmacology (Berl)       Date:  2019-02-13       Impact factor: 4.530

Review 3.  The use of electronic health records for psychiatric phenotyping and genomics.

Authors:  Jordan W Smoller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-05-30       Impact factor: 3.568

4.  Prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Depression among Adults with Inflammatory Chronic Conditions in the United States.

Authors:  Nazneen Fatima Shaikh; Usha Sambamoorthi
Journal:  Psychiatr Q       Date:  2020-03

5.  Abandoning personalization to get to precision in the pharmacotherapy of depression.

Authors:  Roy H Perlis
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

6.  Rare copy number variation in treatment-resistant major depressive disorder.

Authors:  Colm O'Dushlaine; Stephan Ripke; Douglas M Ruderfer; Steven P Hamilton; Maurizio Fava; Dan V Iosifescu; Isaac S Kohane; Susanne E Churchill; Victor M Castro; Caitlin C Clements; Sarah R Blumenthal; Shawn N Murphy; Jordan W Smoller; Roy H Perlis
Journal:  Biol Psychiatry       Date:  2014-01-19       Impact factor: 13.382

Review 7.  An autism case history to review the systematic analysis of large-scale data to refine the diagnosis and treatment of neuropsychiatric disorders.

Authors:  Isaac S Kohane
Journal:  Biol Psychiatry       Date:  2014-06-12       Impact factor: 13.382

Review 8.  How might circadian rhythms control mood? Let me count the ways...

Authors:  Colleen A McClung
Journal:  Biol Psychiatry       Date:  2013-04-01       Impact factor: 13.382

9.  Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis.

Authors:  T Kreisel; M G Frank; T Licht; R Reshef; O Ben-Menachem-Zidon; M V Baratta; S F Maier; R Yirmiya
Journal:  Mol Psychiatry       Date:  2013-12-17       Impact factor: 15.992

10.  Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning.

Authors:  Carl M Sellgren; Jessica Gracias; Bradley Watmuff; Jonathan D Biag; Jessica M Thanos; Paul B Whittredge; Ting Fu; Kathleen Worringer; Hannah E Brown; Jennifer Wang; Ajamete Kaykas; Rakesh Karmacharya; Carleton P Goold; Steven D Sheridan; Roy H Perlis
Journal:  Nat Neurosci       Date:  2019-02-04       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.